ARAAX
Price
$28.21
Change
+$0.10 (+0.36%)
Updated
Jun 2 closing price
Net Assets
1.61B
DRRIX
Price
$17.80
Change
+$0.09 (+0.51%)
Updated
Jun 2 closing price
Net Assets
859.79M
Interact to see
Advertisement

ARAAX vs DRRIX

Header iconARAAX vs DRRIX Comparison
Open Charts ARAAX vs DRRIXBanner chart's image
ARAAX vs DRRIX Comparison Chart in %
View a ticker or compare two or three
VS
ARAAX vs. DRRIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAAX is a StrongBuy and DRRIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARAAX has more cash in the bank: 1.61B vs. DRRIX (860M). DRRIX pays higher dividends than ARAAX: DRRIX (3.67) vs ARAAX (0.50). ARAAX was incepted earlier than DRRIX: ARAAX (11 years) vs DRRIX (16 years). ARAAX (1.40) is less costly to investors than DRRIX (1.01). ARAAX is a more actively managed with annual turnover of: 172.00 vs. DRRIX (119.04). DRRIX has a lower initial minimum investment than ARAAX: DRRIX (1000) vs ARAAX (2500). DRRIX annual gain was more profitable for investors over the last year : 18.19 vs. ARAAX (16.70). DRRIX return over 5 years is better than : 23.03 vs. ARAAX (14.11).
ARAAXDRRIXARAAX / DRRIX
Total Expense Ratio1.400.94149%
Annual Report Gross Expense Ratio1.401.01139%
Fund Existence11 years16 years-
Gain YTD12.3956.751184%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.61B860M187%
Annual Yield % from dividends0.503.6714%
Returns for 1 year16.7018.1992%
Returns for 3 years35.1834.50102%
Returns for 5 years14.1123.0361%
Returns for 10 years57.5158.4098%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLCP24.210.25
+1.04%
Atlanticus Holdings Corp
PRMB24.660.17
+0.69%
Primo Brands Corp.
FGNX8.16-0.32
-3.83%
FG Nexus Inc
NRIX16.36-1.03
-5.92%
Nurix Therapeutics
STTK4.87-0.78
-13.81%
Shattuck Labs